TestNOW-AUTISM (Total FRAA) Quantitative Test

TestNOW-AUTISM (Total FRAA) Quantitative Test

In Vitro Diagnostic Tests
TestNOW-AUTISM (Total FRAA) Quantitative Test
TestNOW-AUTISM (Total FRAA) Quantitative Test
TestNOW-AUTISM (Total FRAA) Quantitative Test

Information

INTENDED USE Affimedix's TestNOW® - AUTISM (TOTAL FRAA) Quantitative Test is an immunochromatography-based one step in vitro test. It is designed for the quantitative determination of total FRAA in human finger-prick blood or serum. This assay provides a preliminary diagnostic test result and can be used for screening of FRAA abnormalities. The liquid chromatography with tandem mass spectrometry (LC-MS/MS) assays or other quantitative
Affimedix, Inc.H3.F10Affimedix, Inc. – a fast-growing Global Medical Device company with its headquarter in Silicon Valley of California, focuses on R & D, product design, development, manufacturing and marketing of “Proprietary” Near-Patient Capillary Blood Diagnostic Tests. We have an extensive knowledge, experience, expertise and specialization in Phage Display and Antibody Engineering Technologies. We are harnessing the Power of these advanced Biotechnologies to develop Novel, Next-Generation “Proprietary” Point-of-Care Diagnostic Tests. Our Product Pipeline includes unique “Sandwich” Tests for Vitamin D, AUTISM (Total FRAA), Testosterone, Cortisol, Vitamin B12, Vitamin B9 (Folate), Estradiol, Progesterone, Omega-3 and other Small Molecule Biomarkers (SMB).

Log in

See all the content and easy-to-use features by logging in or registering!